7711 - 7720 of 9030 Results
Title
Year
- Enteric alpha-synuclein pathology in LRRK2-G2019S Parkinson's disease2017RESTRICTEDTitle: Enteric alpha-synuclein pathology in LRRK2-G2019S Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 40Issue #:Start Page: 83End Page: 84Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.05.001Citation Count: 7
-
OPENTitle: Association of liver fibrosis with cognitive decline in Parkinson’s diseaseJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 119Issue #:Start Page: 10End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2023.11.019Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11198872Citation Count: 7
-
OPENTitle: Assortative mixing in micro-architecturally annotated brain connectomesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 2850End Page: 2850Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-38585-4Best OA location URL: https://www.nature.com/articles/s41467-023-38585-4.pdfCitation Count: 41
-
OPENTitle: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 161End Page: 161Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0456-2Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0456-2Citation Count: 100
-
OPENTitle: Mitochondrial and Endoplasmic Reticulum Stress Trigger Triglyceride Accumulation in Models of Parkinson’s Disease Independent of Mutations in MAPTJournal Name: MetabolitesPublisher: MDPI AGVol: 13Issue #: 1Start Page: 112End Page: 112Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/metabo13010112Best OA location URL: https://www.mdpi.com/2218-1989/13/1/112/pdf?version=1673484935Citation Count: 9
-
OPENTitle: Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenationJournal Name: Aging CellPublisher: WileyVol: 22Issue #: 5Start Page: e13814End Page: e13814Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13814Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.13814Citation Count: 25
-
OPENTitle: Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PDJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 38End Page: 38Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00476-2Best OA location URL: https://www.nature.com/articles/s41531-023-00476-2.pdfCitation Count: 20
-
OPENTitle: Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00460-wBest OA location URL: https://www.nature.com/articles/s41531-023-00460-w.pdfCitation Count: 21
-
OPENTitle: Pure cerebellar ataxia due to bi‐allelic PRDX3 variants including recurring p.Asp202AsnJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 10Issue #: 10Start Page: 1910End Page: 1916Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/acn3.51874Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51874Citation Count: 3
-
OPENTitle: Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 69Issue #:Start Page: 119End Page: 124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7061324Citation Count: 41